The purpose of this study is to investigate the effects of varying particle size on the pharmacokinetics of PH-797804
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Area Under the Curve From Time Zero to Time 72 hours (AUC72)
Area under the plasma concentration time-curve from zero to 72 hours (AUC72)
Time frame: 0,2,3,4,5,6,8,12,24,48,72 hours post-dose
Maximum Observed Plasma Concentration (Cmax)
Time frame: 0,2,3,4,5,6,8,12,24,48,72 hours post-dose
Time to Reach Maximum Observed Plasma Concentration (Tmax)
Time frame: 0,2,3,4,5,6,8,12,24,48,72 hours post-dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Tablet, 6 mg, single dose
Tablet, 6 mg, single dose
Tablet, 6 mg, single dose